desogestrel has been researched along with Vascular Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (92.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E | 1 |
| Ishak, R | 1 |
| Bromham, DR | 1 |
| Killick, S | 1 |
| Comp, PC | 1 |
| Ory, HW | 1 |
| Westhoff, CL | 1 |
14 other study(ies) available for desogestrel and Vascular Diseases
| Article | Year |
|---|---|
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism | 2018 |
Oral contraceptive pills and the risk of venous thromboembolism.
Topics: Biology; Cardiovascular System; Case-Control Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Developed Countries; Developing Countries; Disease; Embolism; Europe; Family Planning Services; Physiology; Research; Risk Factors; Thromboembolism; Vascular Diseases | 1996 |
German court lifts OC prescription ban.
Topics: Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Germany; Jurisprudence; North America; Thromboembolism; United States; Vascular Diseases | 1998 |
Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases | 1991 |
Pill research results in new guidance from CSM.
Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases | 1995 |
Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
Topics: Americas; Bias; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Government Agencies; North America; Organizations; Research; Research Design; Thromboembolism; United Kingdom; United States; United States Food and Drug Administration; United States Public Health Service; Vascular Diseases | 1996 |
Oral contraceptives and venous thromboembolism: consensus conference statement.
Topics: Americas; Bias; Congresses as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Developed Countries; Disease; Embolism; Family Planning Services; North America; Research; Research Design; Thromboembolism; United States; Vascular Diseases | 1996 |
Another pill scare -- should we audit its impact?
Topics: Abortion, Induced; Behavior; Communication; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Developed Countries; Disease; Embolism; Emotions; Europe; Evaluation Studies as Topic; Family Planning Services; Fear; Health Planning; Mass Media; Program Evaluation; Psychology; Thromboembolism; United Kingdom; Vascular Diseases | 1996 |
Don't be scared.
Topics: Behavior; Communication; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Delivery of Health Care; Desogestrel; Developed Countries; Disease; Drug Prescriptions; Embolism; Emotions; Europe; Family Planning Services; Fear; Health Planning; Mass Media; Organization and Administration; Program Evaluation; Psychology; Thromboembolism; United Kingdom; Vascular Diseases | 1996 |
Coagulation and thrombosis with OC use: physiology and clinical relevance.
Topics: Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Disease; Embolism; Family Planning Services; Physiology; Risk Factors; Thromboembolism; Vascular Diseases | 1996 |
Epidemiology of venous thromboembolic disease and OC use.
Topics: Bias; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Disease; Embolism; Epidemiology; Family Planning Services; Health; Public Health; Research; Research Design; Risk Factors; Thromboembolism; Vascular Diseases | 1996 |
A perspective on the concept of "risk".
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Disease; Embolism; Family Planning Services; Risk Factors; Thromboembolism; Vascular Diseases | 1996 |
2 methods for prescribing third-generation OCs.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Desogestrel; Developed Countries; Disease; Drug Prescriptions; Embolism; Europe; Family Planning Services; Health; Health Personnel; Health Planning; Health Planning Guidelines; Organization and Administration; Physicians; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases | 1997 |
Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Developed Countries; Disease; Embolism; England; Europe; Family Planning Services; Health; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases | 1997 |